Literatur
Kahlke V, Fürst A, Leder D, Löhnert M, Schwandner O, Schwandner T, Weimann D, Matzel KE (2016) Sacral nerve stimulation as a therapy for fecal incontinence. Current patient-centered care in Germany. Coloproctology 38:8–21
Maeda Y, Laurberg S, Norton C (2013) Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev 2:CD 007959. doi:10.1002/14651858
Mellgren A, Matzel KE, Pollack J, Hull T, Bernstein M, Graf W, NASHA Dx Study Group (2014) Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil 26:1087–1094
Mellgren A, Wexner SD, Coller JA, Devroede G, Lerew DR, Madoff RD, Hull T (2011) Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum 54:1065–1075 (for the SNS Study Group)
Ratto C, Parello A, Donisi L, Litta F, De Simone V, Spazzafumo L, Giordano P (2011) Novel bulking agent for faecal incontinence. Br J Surg. doi:10.1002/bjs.7699
Ratto C, Litta F, Parello A, Donisi L, De Simone V, Zaccone G (2012) Sacral nerve stimulation in faecal incontinence associated with an anal sphincter lesion: a systematic review. Colorectal Dis 14:e297–304
Ratto C, Donisi L, Litta F, Campenni P, Parcello A (2016) Implantation of SphinKeeper™: a new artificial anal sphincter. Tech Coloproctol 20:59–66
Schwandner O (2012) Stellenwert der konservativen Therapie bei der Stuhlinkontinenz. Zentralbl Chir 137:323–327
Schwandner O, Brunner M, Dietl O (2011) Quality of life and functional results of submucosal injection therapy using dextranomer hyaluronic acid for fecal incontinence. Surg Innov 18:130–135
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
O. Schwandner gibt an, dass kein Interessenkonflikt besteht.
Additional information
Die Zusammenfassung der Studie ist die Übersetzung des englischen Abstracts der Originalpublikation.
Rights and permissions
About this article
Cite this article
Schwandner, O. Gatekeeper™ – eine effektive Option zur Therapie der Stuhlinkontinenz?. coloproctology 39, 104–105 (2017). https://doi.org/10.1007/s00053-017-0140-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00053-017-0140-9